Clinical trial
GnRH Antagonist Prevention of Premature Luteinization in Patients Undergoing IUI
NCT00780858 is registered in ClinicalTrials.gov with IVI Madrid as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- GnRH Antagonist Prevention of Premature Luteinization in Patients Undergoing IUI
- Lead sponsor
- IVI Madrid
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2008
- Completion date
- March 31, 2011
- Enrollment
- 662 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.